SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950136-06-009413
Filing Date
2006-11-13
Accepted
2006-11-13 07:16:44
Documents
6
Period of Report
2006-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 file1.htm 8-K 31216
2 PRESS RELEASE file2.htm EX-99.1 328585
3 ebox.gif GRAPHIC 58
4 spacer.gif GRAPHIC 43
5 cbox.gif GRAPHIC 61
6 html_04149logo.jpg GRAPHIC 11820
  Complete submission text file 0000950136-06-009413.txt   378453
Mailing Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078
Business Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078 44 1382 207506
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 061205101
SIC: 2834 Pharmaceutical Preparations